Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients. — Stella
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(21 sites) Italy
ASST Spedali Civili di Brescia, Brescia, Italy S.C. Ematologia - A.S.O. "SS Antonio e Biagio e Cesare Arrigo", Alessandria S.C. di Ematologia - A.O. S. Croce e Carle, Cuneo Unità funzionale di Ematologia - Azienda Ospedaliera Universitaria Careggi, Florence Ematologia - Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia, Genova Show all 21 locations Last updated January 2026